Abstract. There is evidence that hormone regulation of cellular oncogenes plays an essential role in human cancer.
variable upstream hexanucleotide (11, 12) . Interference between the glucocorticoid receptor and other transcription factors has also been shown (13, 14) . The hormone response elements in the conserved 5'-AGGTCANNNTGACCT-3' sequence is the ERE consensus oligonucleotide (5) . Additionally, 5'-TGACCT-3' half palindromic oligo nucleotides may act synergistically conferring estrogen response to a gene, even at a long distance from the gene promoter (15,16), possibly through estrogen receptorassociated proteins (17) . GREs and EREs have been identified and characterized in a number of cellular genes (18-21), as well as in viral regulatory regions (22) (23) (24) (25) , but little is known about the presense of glucocorticoid and estrogen response elements in cellular oncogenes.
The Η-ras gene, a member of the ras family of protooncogenes, is readily implicated in many types of human cancer both through mutation (26) and abnormal gene expression and is involved in multiple signal transduction pathways, under normal cellular growth as well (27) . The fact that overexpression of ras genes may cause oncogenic transformation (28, 29) and that expression of the normal H-ras gene can act as an onco-supressor (30) , indicate the importance of understanding the way ras genes are regulated. Elevated expression of the ras genes has also been found in a variety of human tumors (for a review see ref. 31 ).
Considering the possible role of hormonal steroids as tumor promoters (32), we computer scanned the human c-Hras\ sequence for potential hormone response elements. We observed a putative GRE motif with 100% similarity in the half palindrome consensus oligonucleotide at position 1261 (GGCCAGACCTGTTCT) of the conserved 3' end of the first intron (33) and a possible ERE motif, with 90% similarity, at position 3007 (GGGCCACCCTGACCT) of the fourth intron of the Η-ras gene. Using gel retardation experiments with nuclear extracts from HeLa and LATK" cell lines, which possess hormone receptors, we showed that both glucocorticoid and estrogen receptors bind their cognate oligonucleotides of Η-ras in a specific way, thus suggesting a role for glucocorticoids and estrogens in regulation of the H-ras gene expression.
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Continuer scanning.
We used Cyborg/Pustell sequence analysis programs to search the nucleotide sequence of the human Ή-ra.vT gene (36) . For identifying possible GREs. we scanned the human c-H-rnv sequence for the highly conserved hexanueleotide 5'-TGTTCT-3' and the complementary 5'-AGAACA-3' sequence. For EREs. the 5'-rGACCT-3' and the complementary 5'-AGGTCA-3' motifs were used. P-end labelled probes hMTIIA GRE (lanes 1-7) and RAS GRE (lanes 8-12) and a 150 fold molar excess over the labelled probe of the unlabelled competitor oligonucleotide (lanes 2-6 and 8-12). Protein-DNA complexes were separated by Polyacrylamide gel electrophoresis and visualized by autoradiography. GR-RAS GRE complex is indicated by the HeLa and LATK" nuclear extacts were used as a source of GR. Fig. 2 shows the interaction of GR and H-ras GRE. The labelled hMTIIA GRE and RAS GRE probes were incubated with HeLa nuclear extract in the absence (lanes 1,7) or presence of unlabelled oligonucleotide competitors. The labelled probes were competed for protein binding with a molar excess of unlabelled oligonucleotides: (lanes 2,8), with each other (lanes 3,9) and with the unrelated SP-1 (lanes 4,10), NF-1 (lanes 5,11 ) and HIV-1LTR AP-1 (lanes 6,12) . A common retarded band was seen in lanes 1 and 7, indicating the presence of a GR-DNA complex. Binding of GR on RAS GRE probe was abolished in the presence of excess of GRE containing competitors, but was unaffected by the other competitors such as SP-1, NF-1 or HIV-1 LTR-AP-1. An equivalent picture resulted from the hMTIIA GRE probe. Fig. 2 showed a strong sequence specificity of a protein for the H-ras DNA target and suggested that this protein was the GR, as it was shown by the common band in lanes 1 and 7 and was displaced only by GRE-related competitors.
A further, more direct demonstration of the GR-H-ras GRE interaction is shown in Fig. 3 . «P-labelled RAS GRE probe was incubated with HeLa nuclear protein, in the absence (lane 3), or presence (lanes 4-6) of increasing amounts of polyclonal anti-human glucocorticoid receptor antibody. Control hMTIIA GRE probe was also incubated, in the absence (lane 1) or presence (lane 2) of polyclonal antihuman GR antibody. Inclusion of the antibody into the reaction mixture led to the disappearance of the specific retarded band, clearly indicating that this was due to GR-DNA interaction.
The hMTIIA GRE and RAS GRE radiolabeled probes were incubated with increasing amounts of GR-containing HeLa (lanes 6-11) and LATK" (lanes 1-5) extracts (Fig. 4) . A retarded band was seen and a stronger GR-DNA complex was observed, in both cell lines, with increasing amount of nuclear extract.
RAS ERE probe, encompassing the H-ras ERE sequence and Vitellogenin ERE probe, encompassing the estrogen response sequence from Xenopus Vitellogenin A2 gene were used for ER binding experiments. The labelled Vitellogenin ERE and RAS ERE probes were incubated with HeLa nuclear extract in the absence (lanes 1,5) or presence of an excess of unlabelled oligonucleotide competitors (Fig. 5) . The labelled probes were competed for protein binding with related (lanes 2,6) and unrelated (lanes 3,4,7,8 ) unlabelled oligos. A common retarded band was seen in lanes 1 and 5, indicating the presence of an ER-DNA complex. Binding of ER on the RAS ERE probe was abolished only in the presence of excess of ERE related competitors, indicating specific binding of estrogen receptor on the H-ras ERE.
ANTIBODY(PO)
ο ο PROBE hMTIIA RAS GRE GRE I Figure 3 . Identification of GR-H-ras GRE complexes by specific antibody. Binding reaction mixtures contained 13 μg of HeLa total nuclear protein, 0.01 pmoles of 32 P labelled hMTIIA GRE and RAS GRE probes, polyclonal anti-human glucocorticoid receptor antibody in amounts indicated above each lane. Protein-DNA complexes were separated as in Fig. 2 . 5) or HeLa (lanes 6-11) nuclear extracts were used. Protein-DNA complexes were separated as in Fig. 2 .
The steroid hormone receptors are one of the most extensively studied group of the known regulatory factors, however, little is still known about hormonal regulation of cellular oncogenes (32, 37, 38) . Using gel retardation assays we observed specific binding of hormone receptors in the li rai gene, at positions which were previously predicted through computer scanning analysis. We showed that glucocorticoid receptor binds a consensus motif at position 1261 of the conserved 3' end of the first intron of the H-ras and that estrogen receptor binds a sequence at position 3007, at the fourth intron of the gene. These results provide data for hormone regulation of the human H-rasl oncogene. Furthermore, potentially active HREs are found in sequences of the H-ras intron, suggesting a regulatory role for introns in the H-ras gene expression. Moreover, the end of the first intron is evolutionarily well conserved (33), suggesting a functional role for the H-ras GRE in human and other organisms as well. The existence of other possible regulatory elements in the vicinity of the H-ras GRE as shown in Fig. 1  (39-41) , also implies a functional role for the H-ras GRE.
Previous data for regulation of the murine H-ras gene by glucocorticoids has been reported (42) . The cooperation between glucocorticoid hormones and the T24 H-ras oncogene in cell transformation (43) suggests the involvement of the H-ras gene in hormonal promotion of breast tumors through abnormal hormonal regulation. In addition, development of breast carcinomas in rats has been shown to be initiated by mutations in the H-ras and K-ras genes and to depend on promotion by estrogens (44) . The latency of ras oncogenes to induce cell transformation in the absence of hormonal stimulation (44) might be due to the inability of ras oncogenes to induce proliferation of the mammary precursor cells. Our experimental results suggest a more direct implication of H-ras in hormonal tumor promotion by proposing hormonal regulation of the H-ras gene (normal or mutated), also providing an explanation for the specificity of tumor development in systems involving ras genes and sexual development.
Using ras p21 as a possible marker for the disease may be of prognostic significance. Depending on the way the H-ras gene is regulated by hormones, an explanation of indications correlating the levels of hormone receptors and prognosis of the disease may also be provided (45) (46) (47) .
In conclusion, more data on the hormone regulation of the H-ras gene through specific receptor binding could be provided by combining in vitro CAT assay experiments and 
